Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2341470465;70466;70467 chr2:178575892;178575891;178575890chr2:179440619;179440618;179440617
N2AB2177365542;65543;65544 chr2:178575892;178575891;178575890chr2:179440619;179440618;179440617
N2A2084662761;62762;62763 chr2:178575892;178575891;178575890chr2:179440619;179440618;179440617
N2B1434943270;43271;43272 chr2:178575892;178575891;178575890chr2:179440619;179440618;179440617
Novex-11447443645;43646;43647 chr2:178575892;178575891;178575890chr2:179440619;179440618;179440617
Novex-21454143846;43847;43848 chr2:178575892;178575891;178575890chr2:179440619;179440618;179440617
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTC
  • RefSeq wild type template codon: CAG
  • Domain: Ig-129
  • Domain position: 70
  • Structural Position: 155
  • Q(SASA): 0.2106
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/F rs759158138 -1.226 0.772 N 0.545 0.196 0.515430650102 gnomAD-2.1.1 1.21E-05 None None None None N None 0 0 None 0 0 None 0 None 0 2.66E-05 0
V/F rs759158138 -1.226 0.772 N 0.545 0.196 0.515430650102 gnomAD-4.0.0 4.77493E-06 None None None None N None 0 0 None 0 0 None 0 0 8.578E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.2149 likely_benign 0.2439 benign -1.665 Destabilizing 0.001 N 0.171 neutral N 0.495804225 None None N
V/C 0.6212 likely_pathogenic 0.6454 pathogenic -1.361 Destabilizing 0.972 D 0.532 neutral None None None None N
V/D 0.4117 ambiguous 0.4844 ambiguous -1.59 Destabilizing 0.326 N 0.573 neutral N 0.453130883 None None N
V/E 0.2718 likely_benign 0.324 benign -1.438 Destabilizing 0.561 D 0.551 neutral None None None None N
V/F 0.1861 likely_benign 0.2014 benign -1.003 Destabilizing 0.772 D 0.545 neutral N 0.462426837 None None N
V/G 0.3395 likely_benign 0.3661 ambiguous -2.135 Highly Destabilizing 0.166 N 0.517 neutral N 0.477911898 None None N
V/H 0.4606 ambiguous 0.511 ambiguous -1.789 Destabilizing 0.009 N 0.499 neutral None None None None N
V/I 0.073 likely_benign 0.071 benign -0.403 Destabilizing 0.166 N 0.447 neutral N 0.436294562 None None N
V/K 0.4378 ambiguous 0.4857 ambiguous -1.211 Destabilizing 0.561 D 0.545 neutral None None None None N
V/L 0.1612 likely_benign 0.1628 benign -0.403 Destabilizing 0.001 N 0.191 neutral N 0.480200054 None None N
V/M 0.1194 likely_benign 0.1176 benign -0.552 Destabilizing 0.818 D 0.538 neutral None None None None N
V/N 0.2235 likely_benign 0.254 benign -1.332 Destabilizing 0.017 N 0.489 neutral None None None None N
V/P 0.9542 likely_pathogenic 0.9574 pathogenic -0.792 Destabilizing 0.901 D 0.591 neutral None None None None N
V/Q 0.2827 likely_benign 0.3191 benign -1.265 Destabilizing 0.901 D 0.589 neutral None None None None N
V/R 0.3993 ambiguous 0.4382 ambiguous -1.034 Destabilizing 0.561 D 0.612 neutral None None None None N
V/S 0.1838 likely_benign 0.2148 benign -2.021 Highly Destabilizing 0.209 N 0.487 neutral None None None None N
V/T 0.1351 likely_benign 0.1512 benign -1.728 Destabilizing 0.007 N 0.177 neutral None None None None N
V/W 0.8246 likely_pathogenic 0.8424 pathogenic -1.369 Destabilizing 0.991 D 0.633 neutral None None None None N
V/Y 0.5063 ambiguous 0.5362 ambiguous -0.982 Destabilizing 0.818 D 0.547 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.